Oivi makes hospital-quality retinal screening affordable in primary care with a robotic, AI-guided camera that captures high-quality images with minimal training. We start with reimbursed diabetic retinopathy screening to close care gaps and improve quality score. Fast and easy during routine visits without disrupting workflow. 130,000+ patients screened. Scaling in the U.S. Subscription with no upfront clinic cost. Preparing a $10M Series A to accelerate deployments and scale commercially.
New Day Diagnostics
xxx | New Day Diagnostics (NDDx) is a precision diagnostics and bioresearch company expanding access to colorectal cancer screening and advancing clinical innovation. Our flagship is ColoHealth (FDA-approved), supported by a growing portfolio that includes ColoHealth Direct LDT—a lab-developed option built to simplify ordering, improve patient completion, and scale across clinical, employer, and telehealth channels. We focus on quality, compliance, and partnerships to deliver reliable results.
Naviant
Naviant, a leader in intelligent automation and process consulting, helps organizations reimagine work. With 35+ years of experience and a process-first approach, Naviant delivers tailored solutions including AI, agentic automation, IDP, ECM, RPA, and more. Their flexible Managed Services simplify operations, enabling customers to focus on business while Naviant manages, enhances, and scales automation solutions.
Molecular Testing Labs
Molecular Testing Labs (MTL) is a leading CAP-accredited and CLIA-certified health science and precision clinical laboratory company specializing in high-complexity molecular testing with an extensive portfolio of services. Dedicated to improving health equity and outcomes, MTL is on a mission to make diagnostic care more accessible in hard-to-reach communities through innovative diagnostic solutions. We provide customized collection devices, state-of-the-art technology, advanced logistics, and cutting-edge research and development to advance clinical and scientific research initiatives. Additionally, recognizing the critical importance of representative study designs, MTL empowers pharmaceutical companies to conduct decentralized trials with inclusivity and precision. | Molecular Testing Labs is a B2B diagnostics partner providing private-label, home-collected testing solutions for health plans and digital health companies. We support telehealth and digital health platforms with personalized diagnostics, and we help health plans close gaps in care through end-to-end at-home testing programs that drive HEDIS and Star performance.